|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
|
US8231899B2
(en)
*
|
1998-09-10 |
2012-07-31 |
Nycomed Danmark Aps |
Quick release pharmaceutical compositions of drug substances
|
|
SA99191255B1
(ar)
|
1998-11-30 |
2006-11-25 |
جي دي سيرل اند كو |
مركبات سيليكوكسيب celecoxib
|
|
US20020035107A1
(en)
|
2000-06-20 |
2002-03-21 |
Stefan Henke |
Highly concentrated stable meloxicam solutions
|
|
EP1250921A1
(de)
*
|
2001-04-21 |
2002-10-23 |
BOEHRINGER INGELHEIM INTERNATIONAL GmbH |
Schnell zerfallende Meloxicam enthaltende Tablette
|
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
|
DE10161077A1
(de)
|
2001-12-12 |
2003-06-18 |
Boehringer Ingelheim Vetmed |
Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
|
|
US20030161875A1
(en)
*
|
2002-02-27 |
2003-08-28 |
Deepak Murpani |
Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
|
|
US8992980B2
(en)
|
2002-10-25 |
2015-03-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Water-soluble meloxicam granules
|
|
US20040109889A1
(en)
*
|
2002-12-04 |
2004-06-10 |
Bunick Frank J. |
Surface treatment composition for soft substrates
|
|
US20040202717A1
(en)
*
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
|
WO2005004915A2
(en)
*
|
2003-07-09 |
2005-01-20 |
Boehringer Ingelheim International Gmbh |
Compositions comprising meloxicam
|
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
EP1568369A1
(de)
|
2004-02-23 |
2005-08-31 |
Boehringer Ingelheim Vetmedica Gmbh |
Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
|
|
US20050220877A1
(en)
*
|
2004-03-31 |
2005-10-06 |
Patel Ashish A |
Bilayer tablet comprising an antihistamine and a decongestant
|
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
BRPI0508063A
(pt)
*
|
2004-06-29 |
2007-07-17 |
Nycomed Danmark Aps |
processo para a manufatura de uma composição farmacêutica, nsaid, e, composição farmacêutica
|
|
JP5490347B2
(ja)
*
|
2005-05-27 |
2014-05-14 |
エスエス製薬株式会社 |
経口投与用製剤
|
|
JO3352B1
(ar)
|
2005-06-17 |
2019-03-13 |
Apr Applied Pharma Res Sa |
صيغ دايكلوفيناك وطرق استخدامه
|
|
CA2614850A1
(en)
|
2005-07-20 |
2007-01-25 |
Panacea Biotec Ltd. |
Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
|
|
CA2615063A1
(en)
*
|
2005-07-22 |
2007-02-01 |
Myriad Genetics, Inc. |
High drug load formulations and dosage forms
|
|
HUE028588T2
(hu)
|
2005-12-13 |
2016-12-28 |
Incyte Holdings Corp |
Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
|
|
EP1965774A2
(de)
*
|
2005-12-30 |
2008-09-10 |
Cogentus Pharmaceuticals, Inc. |
Orale pharmazeutische formulierungen mit nichtsteroidalen entzündungshemmern und säurehemmern
|
|
JP2009535409A
(ja)
*
|
2006-05-03 |
2009-10-01 |
コーワ ファーマシューティカルズ アメリカ,インコーポレイティド |
即効性ジクロフェナク−オピオイド組成物に基づく急性疼痛医薬
|
|
EP2043613A1
(de)
*
|
2006-07-14 |
2009-04-08 |
Fmc Corporation |
Feste form
|
|
WO2008062449A2
(en)
*
|
2006-09-18 |
2008-05-29 |
Glenmark Pharmaceuticals Limited |
A novel pharmaceutical soft gel composition containing dexibuprofen and paracetamol
|
|
US20080081067A1
(en)
*
|
2006-10-03 |
2008-04-03 |
Gupta Manishkumar |
Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
|
|
US20080311162A1
(en)
*
|
2007-05-16 |
2008-12-18 |
Olivia Darmuzey |
Solid form
|
|
EP2740731B1
(de)
*
|
2007-06-13 |
2016-03-23 |
Incyte Holdings Corporation |
Kristalline Salze des Janus-Kinasehemmers (R)-3-(4-(7H-pyrrolo[2,3-D]pyrimidin-4-YL)-1H-pyrazol-1-YL)-3-cyclopentylpropanenitril
|
|
EP2471515A3
(de)
|
2007-09-14 |
2012-12-26 |
Wockhardt Limited |
Rhein- oder Diacereinzusammensetzungen
|
|
EP3090739A1
(de)
|
2008-01-04 |
2016-11-09 |
Schabar Research Associates LLC |
Zusammensetzungen aus naproxen-natriumsalz und nizatidin
|
|
AU2009249069A1
(en)
|
2008-05-20 |
2009-11-26 |
Neurogesx, Inc. |
Carbonate prodrugs and methods of using the same
|
|
JP5757864B2
(ja)
*
|
2008-05-20 |
2015-08-05 |
ニューロジェシックス, インコーポレイテッド |
水溶性アセトアミノフェン類似体
|
|
KR20110079641A
(ko)
|
2008-09-09 |
2011-07-07 |
아스트라제네카 아베 |
제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법
|
|
BRPI1012108B8
(pt)
|
2009-05-22 |
2021-05-25 |
Incyte Corp |
composto 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octa no- ou heptano-nitrila, sua composição, seus usos e processo para preparar um sal de ácido fosfórico
|
|
MX2011013467A
(es)
|
2009-06-25 |
2012-02-13 |
Astrazeneca Ab |
Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine).
|
|
NZ597534A
(en)
*
|
2009-06-25 |
2013-09-27 |
Pozen Inc |
Method for treating a patient in need of aspirin therapy
|
|
TW201113285A
(en)
*
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
US9101529B2
(en)
|
2009-10-12 |
2015-08-11 |
Boehringer Ingelheim Vetmedica Gmbh |
Containers for compositions comprising meloxicam
|
|
WO2011107150A1
(en)
|
2010-03-03 |
2011-09-09 |
Boehringer Ingelheim Vetmedica Gmbh |
Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
|
|
CA2792508C
(en)
|
2010-03-10 |
2018-01-16 |
Incyte Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
US9795568B2
(en)
|
2010-05-05 |
2017-10-24 |
Boehringer Ingelheim Vetmedica Gmbh |
Low concentration meloxicam tablets
|
|
EA202091303A3
(ru)
|
2010-05-21 |
2021-05-31 |
Инсайт Холдингс Корпорейшн |
Композиция ингибитора jak для местного применения
|
|
EP2394641A1
(de)
|
2010-05-30 |
2011-12-14 |
Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi |
Pharmazeutische Formulationen von Lornoxicam
|
|
ES2536415T3
(es)
|
2010-11-19 |
2015-05-25 |
Incyte Corporation |
Pirrolopiridinas y pirrolopirimidinas sustituidas heterocíclicas como inhibidores de JAK
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
WO2012146314A1
(en)
|
2011-04-29 |
2012-11-01 |
Refarmed Chemicals Sa |
Thin gelatin capsules for rapid drug release in the mouth
|
|
US8691807B2
(en)
|
2011-06-20 |
2014-04-08 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
JP2012012411A
(ja)
*
|
2011-10-03 |
2012-01-19 |
Ssp Co Ltd |
経口投与用製剤
|
|
US9539214B2
(en)
|
2011-12-28 |
2017-01-10 |
Pozen Inc. |
Compositions and methods for delivery of omeprazole plus acetylsalicylic acid
|
|
WO2013158814A1
(en)
|
2012-04-18 |
2013-10-24 |
Mallinckrodt Llc |
Immediate release, abuse deterrent pharmaceutical compositions
|
|
US20130310435A1
(en)
|
2012-05-18 |
2013-11-21 |
Gruenenthal Gmbh |
Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
US9308196B2
(en)
*
|
2012-05-18 |
2016-04-12 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam
|
|
US9320729B2
(en)
|
2012-05-18 |
2016-04-26 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
|
|
US9855286B2
(en)
|
2012-05-18 |
2018-01-02 |
Gruenenthal Gmbh |
Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
|
|
US20130310385A1
(en)
|
2012-05-18 |
2013-11-21 |
Gruenenthal Gmbh |
Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants
|
|
KR102242077B1
(ko)
|
2012-11-15 |
2021-04-20 |
인사이트 홀딩스 코포레이션 |
룩솔리티니브의 서방성 제형
|
|
EP3489239B1
(de)
|
2013-03-06 |
2021-09-15 |
Incyte Holdings Corporation |
Verfahren und zwischenprodukte zur herstellung eines jak-hemmers
|
|
BR112015021002B8
(pt)
|
2013-03-15 |
2023-03-28 |
Mallinckrodt Llc |
Forma de dosagem sólida farmacêutica compreendendo um ingrediente farmacêutico ativo
|
|
JP2013216701A
(ja)
*
|
2013-07-29 |
2013-10-24 |
Ssp Co Ltd |
経口投与用製剤
|
|
KR101890649B1
(ko)
*
|
2013-07-30 |
2018-09-28 |
라이온 가부시키가이샤 |
정제
|
|
MX376856B
(es)
|
2013-08-07 |
2025-03-07 |
Incyte Holdings Corp |
Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1 (cinasa de janus 1).
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
PL3164117T3
(pl)
|
2014-07-03 |
2024-03-11 |
SpecGx LLC |
Preparaty zapewniające natychmiastowe uwalnianie i powstrzymujące przed nadużywaniem, zawierające polisacharydy inne niż celuloza
|
|
EP3349853B1
(de)
|
2015-09-15 |
2023-12-20 |
Praxis Bioresearch, LLC |
Prodrugs von fencamfamin
|
|
UA126916C2
(uk)
|
2017-04-27 |
2023-02-22 |
Др. Редді'З Лабораторіз Лімітед |
Фармацевтична композиція кеторолаку
|
|
TW201924683A
(zh)
|
2017-12-08 |
2019-07-01 |
美商英塞特公司 |
用於治療骨髓增生性贅瘤的低劑量組合療法
|
|
MD3746429T2
(ro)
|
2018-01-30 |
2022-08-31 |
Incyte Corp |
Procedee pentru prepararea de (1-(3-fluoro-2-(trifluorometil)izonicotinil)piperidin-4-onă)
|
|
KR20260080448A
(ko)
|
2018-03-30 |
2026-06-02 |
인사이트 코포레이션 |
Jak 억제제를 사용하는 화농성 한선염의 치료
|
|
JP7170437B2
(ja)
*
|
2018-06-29 |
2022-11-14 |
小林製薬株式会社 |
内服用医薬組成物
|
|
WO2020068510A1
(en)
|
2018-09-25 |
2020-04-02 |
SpecGx LLC |
Abuse deterrent immediate release capsule dosage forms
|
|
US11779541B2
(en)
*
|
2019-03-26 |
2023-10-10 |
Johnson & Johnson Consumer Inc. |
Immediate release dosage form
|
|
TW202131926A
(zh)
|
2019-11-22 |
2021-09-01 |
美商英塞特公司 |
包含alk2抑制劑及jak2抑制劑的組合療法
|
|
JP7499025B2
(ja)
*
|
2019-12-27 |
2024-06-13 |
小林製薬株式会社 |
内服用医薬組成物
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
US12514846B2
(en)
|
2020-07-15 |
2026-01-06 |
Schabar Research Associates Llc |
Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach
|
|
JP2023534810A
(ja)
|
2020-07-15 |
2023-08-14 |
シャバー リサーチ アソシエイツ エルエルシー |
急性痛の処置並びに胸やけの重症度及び/又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物
|
|
US11324727B2
(en)
|
2020-07-15 |
2022-05-10 |
Schabar Research Associates, Llc |
Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
|